SOLLA, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 143.887
NA - Nord America 7.755
AS - Asia 3.686
SA - Sud America 452
AF - Africa 82
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 9
Totale 155.900
Nazione #
IT - Italia 141.766
US - Stati Uniti d'America 7.631
SG - Singapore 1.393
CN - Cina 1.254
UA - Ucraina 516
SE - Svezia 466
BR - Brasile 354
VN - Vietnam 352
DE - Germania 245
GB - Regno Unito 218
FI - Finlandia 216
FR - Francia 195
KR - Corea 120
IN - India 116
HK - Hong Kong 94
CA - Canada 76
BD - Bangladesh 52
JP - Giappone 45
NL - Olanda 45
IQ - Iraq 44
RU - Federazione Russa 34
AR - Argentina 33
PL - Polonia 29
PK - Pakistan 27
MX - Messico 24
TR - Turchia 21
ID - Indonesia 20
AT - Austria 19
AU - Australia 19
BE - Belgio 19
ES - Italia 19
ZA - Sudafrica 18
RO - Romania 17
IL - Israele 16
VE - Venezuela 15
IR - Iran 14
MA - Marocco 14
CZ - Repubblica Ceca 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
CU - Cuba 11
JO - Giordania 11
IE - Irlanda 10
EC - Ecuador 9
KE - Kenya 9
NZ - Nuova Zelanda 9
CH - Svizzera 8
MY - Malesia 8
PY - Paraguay 8
CO - Colombia 7
EG - Egitto 7
GR - Grecia 7
PH - Filippine 7
TH - Thailandia 7
TW - Taiwan 7
EU - Europa 6
GH - Ghana 6
LT - Lituania 6
OM - Oman 6
PT - Portogallo 6
TN - Tunisia 6
BG - Bulgaria 5
BO - Bolivia 5
CI - Costa d'Avorio 5
PE - Perù 5
AZ - Azerbaigian 4
DK - Danimarca 4
EE - Estonia 4
KZ - Kazakistan 4
LB - Libano 4
UY - Uruguay 4
CY - Cipro 3
DZ - Algeria 3
KG - Kirghizistan 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
BY - Bielorussia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
NG - Nigeria 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
DO - Repubblica Dominicana 1
Totale 155.879
Città #
Cagliari 138.699
Uta 2.449
Singapore 729
Ashburn 678
Fairfield 672
Woodbridge 583
Chandler 543
San Jose 471
Houston 360
Boardman 313
Wilmington 302
Nyköping 296
Dallas 288
Beijing 268
Ann Arbor 267
Seattle 267
Jacksonville 253
Cambridge 204
Dearborn 189
Los Angeles 147
Helsinki 128
Santa Clara 123
Shanghai 112
Nanjing 106
Lauterbourg 98
Ho Chi Minh City 97
New York 93
The Dalles 92
Hong Kong 83
Hefei 80
Council Bluffs 76
Boston 74
Hanoi 72
Seoul 72
Buffalo 56
Milan 55
Redwood City 51
San Diego 50
Rome 43
Orem 39
Sassari 37
Atlanta 35
Toronto 35
Shenyang 34
São Paulo 34
Dong Ket 32
London 31
Changsha 29
Frankfurt am Main 29
Nanchang 25
Chicago 24
Warsaw 24
Redondo Beach 23
Tianjin 22
Da Nang 21
Guangzhou 21
Jiaxing 21
Munich 21
Tokyo 21
Brooklyn 19
Chennai 19
Mountain View 19
Phoenix 19
Haiphong 18
Norwalk 18
Verona 18
Brussels 17
San Francisco 17
Baghdad 16
Hebei 15
Rio de Janeiro 15
Amsterdam 14
Icheon-si 14
Orange 14
Washington 14
Wuhan 14
Dhaka 13
Jinan 13
Nuremberg 13
Zhengzhou 13
Montreal 12
Manchester 11
Mumbai 11
Ningbo 11
Pune 11
Tashkent 11
Yongin-si 11
Amman 10
Bari 10
Auburn Hills 9
Augusta 9
Lahore 9
Porto Alegre 9
Stockholm 9
Casablanca 8
Deva 8
Erbil 8
Leawood 8
Piscataway 8
San Mateo 8
Totale 150.620
Nome #
Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease 5.420
Drosophila model for parkinson’s disease: function, anatomy and screening with phytoterapics from Sardinian and Indian flora (Withania somnifera and Mucuna pruriens) 5.071
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: drug effects of Withania somnifera (Dunal) administration 5.017
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with Parkinson’s disease 4.465
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.284
OLFACTORY DYSFUNCTION AS POTENTIAL BIOMARKER IN NEURODEGENERATIVE DISORDERS 4.040
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 3.859
Impaired sense of smell in a Drosophila Parkinson's model. 3.657
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 3.538
Drosophila Parkinson's mutant display olfactory impairment both to natural and synthetic compounds 3.504
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.472
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.178
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.099
Olfactory function and apathy as potential biomarker in patients with Parkinson's disease 3.035
The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens 3.024
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 2.937
Olfactory function and age: a sniffin’ sticks extended test study performed in Sardinia 2.916
Influence of parkinsonism on Hitler's decision-making 2.908
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.498
Gender differences in olfactory function in patients with Parkinson's disease. 2.468
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion 2.355
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.304
Occurence and DAergic therapy correlates of REM sleep behavior disorder in patients with Parkinson Disease 2.160
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.158
Suicide and Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease 2.124
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.061
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 2.055
Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm 2.050
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.013
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 1.922
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.895
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.885
Discordance between Dopamine transporter deficit and motor symptoms in a case of REM sleep behavior disorder 1.884
Leucine-rich repeat kinase 2 (LRRK2) gene mutations in degenerative parkinsonism 1.682
Internal carotid artery dissection causing ischemic stroke during pole sport practice 1.559
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 1.553
null 1.548
Usefulness of levodopa in the treatment of patients affected by schizophrenia and parkinsonism with DAT scan suggestive of a severe presinaptic dopaminergic deficiency 1.514
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 1.425
null 1.368
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia 1.351
Towards the characterization of the role of neurosteroids in pathological gambling: Clinical and preclinical studies 1.327
Clinical evaluation of sleep disorders in a large population of Parkinsonians 1.323
Delayed effect of age at onset on disability progression in multiple sclerosis 1.303
Occurrence and Daergic therapy correlates of REM sleep behaviour disorder in a large population of patients with Parkinson's disease 1.298
Axonal Charcot-Marie-Tooth disease, distal hereditary motor neuropathy and spastic paraplegia in a large Sardinian family with Heat Shock Protein RW mutation: an expression of a common spectrum? 1.245
Analysis of parkin exon rearrangements and sequence variants in LRRK2 mutations carriers 1.113
Genetic analysis for five LRRK2 mutations in sardinian patients with familial or sporadic Parkinson’s disease 1.092
Factors Influencing Adaptation and Performance at Physical Exercise in Complex Congenital Heart Diseases after Surgical Repair 1.055
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 1.043
Occurance and Daergic therapy correlates of REM sleep behaviour disorder in a large population of patients with Parkinson's disease 1.027
Delusional jealousy in Parkinson's disease patients with and without dementia 1.024
Bipolar affective disorder and Parkinson's disease: a rare, insidious and often unrecognized association 999
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease. 953
Presence and severity of apathy in Sardinian patients affected by Parkinson’s disease and correlation with non-motor symptoms 936
Dopamine dysregulation syndrome in Parkinson's disease patients with unsatisfactory switching from immediate to extended release pramipexole: a further clue to incentive sensitization mechanisms? 899
Parkin sequence variants in Parkinson’s disease patients with LRRK2 mutations 885
Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient 877
Dopamine dysregulation syndrome in Parkinson's disease patients on duodenal levodopa infusion 871
Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients 864
Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study 840
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms 806
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature 792
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 790
Sintomi non motori e disautonomia cardiovascolare in pazienti sardi affetti da malattia di parkinson con e senza mutazioni del gene LRRK2 787
Rasagiline withdrawal Syndrome in Parkinson’s Disease 749
Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease 744
Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson’s Disease 727
Finasteride attenuates pathological gambling in patients with Parkinson disease 714
null 692
Olfactory hallucinations in Parkinson’s disease patients and the role of their evaluation in clinical practice. 641
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non‑tremor‑dominant subtypes really uncorrelated to olfactory impairment? 640
Othello syndrome in Parkinson disease patients without dementia 611
Gender-Related Differences in the Correlation between Odor Threshold, Discrimination, Identification, and Cognitive Reserve Index in Healthy Subjects 587
Discordance between dopamine transporter deficit and motor symptoms in a case of REM behaviour disorder 568
Pisa syndrome in a patient with progressive supranuclear palsy 563
Dopaminergic-induced paraphilias associated with impulse control and related disorders in patients with Parkinson disease 555
Lateral trunk flexion and Pisa syndrome in Parkinson's disease. Are they really always different conditions although denoting similar features? 549
Pathological gambling, delusional parasitosis and adipsia as a post-haemorrhagic syndrome: a case report 541
[123I] FP-CIT single photon emission computed tomography findings in drug-induced parkinsonism 538
Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment 537
Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation 515
Treatment of Benign Essential Blepharospasm With Finasteride: A Case Report 511
Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients 505
Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: a case report 492
[I-123]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 481
Exposure to TNF inhibitors is rare at MOGAD presentation 472
Motor and non-motor disorders in parkinsonian patients with LRRK2 mutations 466
null 463
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications 461
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations. 455
Epilepsy and sexual funtcion in male and female subjects treated with old and new AEDs, on poly or monotherapy: Preliminary data (Conference Paper) [Epilessia e funzione sessuale in pazienti di sesso maschile e femminile trattati con vecchi e nuovi FAE, in poli e monoterapia: Dati preliminari] 417
Role of rapid eye movement sleep behavior disorder (RBD) and other clinical factors in the prediction of cognitive impairment in Parkinson’s disease 416
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo (R)) 415
Protein Tyrosine phosphatase receptor type C (CD45) C77G mutation and susceptibility to multiple sclerosis, autoimmune and infectious diseases 401
Atypical parkinsonism in a patient with LRRK2 R1441c mutation 377
Compulsive original artistic creativity in Parkinson's disease: a new dimension of the spectrum of reward-seeking behaviours 350
Dopaminergic replacement therapy enhances artistic productivity in patients with Parkinson's disease 344
Olfactory Function as a Potential Predictor of Cognitive Impairment in Men and Women 340
Neurological and Psychiatric Disorders in the COVID-19 Era 327
Totale 153.569
Categoria #
all - tutte 198.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 198.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.967 0 0 0 0 0 0 0 0 0 0 1.906 1.061
2021/20226.629 834 488 284 468 568 509 376 346 536 639 784 797
2022/20239.178 750 1.110 1.155 739 789 872 467 887 561 655 735 458
2023/202410.056 572 543 420 792 919 1.368 1.258 741 532 810 1.065 1.036
2024/202517.352 2.798 3.463 2.267 4.022 1.164 1.304 1.089 147 366 206 230 296
2025/20266.061 480 292 638 565 534 603 942 430 533 907 137 0
Totale 156.184